Exelixis
EXEL
#1629
Rank
A$16.56 B
Marketcap
$59.20
Share price
1.79%
Change (1 day)
65.24%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $78.72 AUD on 2000-07-26

Lowest end of day price: $2.06 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$60.16-0.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
$86.23-0.72%๐Ÿ‡ซ๐Ÿ‡ท France
$138.41-0.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$95.26 0.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$488.60-0.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$248.31 1.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$39.48 0.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.37 1.37%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.97 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA